Product Code: ETC13365882 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
Global Pharmacogenomics Technology Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Pharmacogenomics Technology Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Pharmacogenomics Technology Market Revenues & Volume, 2021 & 2031F |
3.3 Global Pharmacogenomics Technology Market - Industry Life Cycle |
3.4 Global Pharmacogenomics Technology Market - Porter's Five Forces |
3.5 Global Pharmacogenomics Technology Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Pharmacogenomics Technology Market Revenues & Volume Share, By Technology Type, 2021 & 2031F |
3.7 Global Pharmacogenomics Technology Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Global Pharmacogenomics Technology Market Revenues & Volume Share, By Testing Method, 2021 & 2031F |
3.9 Global Pharmacogenomics Technology Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.10 Global Pharmacogenomics Technology Market Revenues & Volume Share, By Market Driver, 2021 & 2031F |
4 Global Pharmacogenomics Technology Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Pharmacogenomics Technology Market Trends |
6 Global Pharmacogenomics Technology Market, 2021 - 2031 |
6.1 Global Pharmacogenomics Technology Market, Revenues & Volume, By Technology Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Pharmacogenomics Technology Market, Revenues & Volume, By Genotyping, 2021 - 2031 |
6.1.3 Global Pharmacogenomics Technology Market, Revenues & Volume, By Next-Generation Sequencing, 2021 - 2031 |
6.1.4 Global Pharmacogenomics Technology Market, Revenues & Volume, By Gene Expression Profiling, 2021 - 2031 |
6.1.5 Global Pharmacogenomics Technology Market, Revenues & Volume, By Bioinformatics Solutions, 2021 - 2031 |
6.1.6 Global Pharmacogenomics Technology Market, Revenues & Volume, By Companion Diagnostics, 2021 - 2031 |
6.2 Global Pharmacogenomics Technology Market, Revenues & Volume, By Application, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Pharmacogenomics Technology Market, Revenues & Volume, By Personalized Medicine, 2021 - 2031 |
6.2.3 Global Pharmacogenomics Technology Market, Revenues & Volume, By Drug Response Analysis, 2021 - 2031 |
6.2.4 Global Pharmacogenomics Technology Market, Revenues & Volume, By Oncology Treatment, 2021 - 2031 |
6.2.5 Global Pharmacogenomics Technology Market, Revenues & Volume, By Adverse Drug Reactions, 2021 - 2031 |
6.2.6 Global Pharmacogenomics Technology Market, Revenues & Volume, By Clinical Trials, 2021 - 2031 |
6.3 Global Pharmacogenomics Technology Market, Revenues & Volume, By Testing Method, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Pharmacogenomics Technology Market, Revenues & Volume, By PCR-Based, 2021 - 2031 |
6.3.3 Global Pharmacogenomics Technology Market, Revenues & Volume, By Microarray, 2021 - 2031 |
6.3.4 Global Pharmacogenomics Technology Market, Revenues & Volume, By Whole Genome Sequencing, 2021 - 2031 |
6.3.5 Global Pharmacogenomics Technology Market, Revenues & Volume, By AI-Based Analytics, 2021 - 2031 |
6.3.6 Global Pharmacogenomics Technology Market, Revenues & Volume, By DNA Microarray, 2021 - 2031 |
6.4 Global Pharmacogenomics Technology Market, Revenues & Volume, By End User, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Global Pharmacogenomics Technology Market, Revenues & Volume, By Pharma Companies, 2021 - 2031 |
6.4.3 Global Pharmacogenomics Technology Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.4.4 Global Pharmacogenomics Technology Market, Revenues & Volume, By Research Labs, 2021 - 2031 |
6.4.5 Global Pharmacogenomics Technology Market, Revenues & Volume, By Academic Institutions, 2021 - 2031 |
6.4.6 Global Pharmacogenomics Technology Market, Revenues & Volume, By Diagnostic Centers, 2021 - 2031 |
6.5 Global Pharmacogenomics Technology Market, Revenues & Volume, By Market Driver, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 Global Pharmacogenomics Technology Market, Revenues & Volume, By Advancements in Precision Medicine, 2021 - 2031 |
6.5.3 Global Pharmacogenomics Technology Market, Revenues & Volume, By Increase in Genetic Testing, 2021 - 2031 |
6.5.4 Global Pharmacogenomics Technology Market, Revenues & Volume, By Growing Interest in Targeted Therapy, 2021 - 2031 |
6.5.5 Global Pharmacogenomics Technology Market, Revenues & Volume, By Expansion in Pharmacovigilance, 2021 - 2031 |
6.5.6 Global Pharmacogenomics Technology Market, Revenues & Volume, By Demand for Tailored Therapeutics, 2021 - 2031 |
7 North America Pharmacogenomics Technology Market, Overview & Analysis |
7.1 North America Pharmacogenomics Technology Market Revenues & Volume, 2021 - 2031 |
7.2 North America Pharmacogenomics Technology Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Pharmacogenomics Technology Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Pharmacogenomics Technology Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Pharmacogenomics Technology Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Pharmacogenomics Technology Market, Revenues & Volume, By Technology Type, 2021 - 2031 |
7.4 North America Pharmacogenomics Technology Market, Revenues & Volume, By Application, 2021 - 2031 |
7.5 North America Pharmacogenomics Technology Market, Revenues & Volume, By Testing Method, 2021 - 2031 |
7.6 North America Pharmacogenomics Technology Market, Revenues & Volume, By End User, 2021 - 2031 |
7.7 North America Pharmacogenomics Technology Market, Revenues & Volume, By Market Driver, 2021 - 2031 |
8 Latin America (LATAM) Pharmacogenomics Technology Market, Overview & Analysis |
8.1 Latin America (LATAM) Pharmacogenomics Technology Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Pharmacogenomics Technology Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Pharmacogenomics Technology Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Pharmacogenomics Technology Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Pharmacogenomics Technology Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Pharmacogenomics Technology Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Pharmacogenomics Technology Market, Revenues & Volume, By Technology Type, 2021 - 2031 |
8.4 Latin America (LATAM) Pharmacogenomics Technology Market, Revenues & Volume, By Application, 2021 - 2031 |
8.5 Latin America (LATAM) Pharmacogenomics Technology Market, Revenues & Volume, By Testing Method, 2021 - 2031 |
8.6 Latin America (LATAM) Pharmacogenomics Technology Market, Revenues & Volume, By End User, 2021 - 2031 |
8.7 Latin America (LATAM) Pharmacogenomics Technology Market, Revenues & Volume, By Market Driver, 2021 - 2031 |
9 Asia Pharmacogenomics Technology Market, Overview & Analysis |
9.1 Asia Pharmacogenomics Technology Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Pharmacogenomics Technology Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Pharmacogenomics Technology Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Pharmacogenomics Technology Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Pharmacogenomics Technology Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Pharmacogenomics Technology Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Pharmacogenomics Technology Market, Revenues & Volume, By Technology Type, 2021 - 2031 |
9.4 Asia Pharmacogenomics Technology Market, Revenues & Volume, By Application, 2021 - 2031 |
9.5 Asia Pharmacogenomics Technology Market, Revenues & Volume, By Testing Method, 2021 - 2031 |
9.6 Asia Pharmacogenomics Technology Market, Revenues & Volume, By End User, 2021 - 2031 |
9.7 Asia Pharmacogenomics Technology Market, Revenues & Volume, By Market Driver, 2021 - 2031 |
10 Africa Pharmacogenomics Technology Market, Overview & Analysis |
10.1 Africa Pharmacogenomics Technology Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Pharmacogenomics Technology Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Pharmacogenomics Technology Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Pharmacogenomics Technology Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Pharmacogenomics Technology Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Pharmacogenomics Technology Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Pharmacogenomics Technology Market, Revenues & Volume, By Technology Type, 2021 - 2031 |
10.4 Africa Pharmacogenomics Technology Market, Revenues & Volume, By Application, 2021 - 2031 |
10.5 Africa Pharmacogenomics Technology Market, Revenues & Volume, By Testing Method, 2021 - 2031 |
10.6 Africa Pharmacogenomics Technology Market, Revenues & Volume, By End User, 2021 - 2031 |
10.7 Africa Pharmacogenomics Technology Market, Revenues & Volume, By Market Driver, 2021 - 2031 |
11 Europe Pharmacogenomics Technology Market, Overview & Analysis |
11.1 Europe Pharmacogenomics Technology Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Pharmacogenomics Technology Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Pharmacogenomics Technology Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Pharmacogenomics Technology Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Pharmacogenomics Technology Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Pharmacogenomics Technology Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Pharmacogenomics Technology Market, Revenues & Volume, By Technology Type, 2021 - 2031 |
11.4 Europe Pharmacogenomics Technology Market, Revenues & Volume, By Application, 2021 - 2031 |
11.5 Europe Pharmacogenomics Technology Market, Revenues & Volume, By Testing Method, 2021 - 2031 |
11.6 Europe Pharmacogenomics Technology Market, Revenues & Volume, By End User, 2021 - 2031 |
11.7 Europe Pharmacogenomics Technology Market, Revenues & Volume, By Market Driver, 2021 - 2031 |
12 Middle East Pharmacogenomics Technology Market, Overview & Analysis |
12.1 Middle East Pharmacogenomics Technology Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Pharmacogenomics Technology Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Pharmacogenomics Technology Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Pharmacogenomics Technology Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Pharmacogenomics Technology Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Pharmacogenomics Technology Market, Revenues & Volume, By Technology Type, 2021 - 2031 |
12.4 Middle East Pharmacogenomics Technology Market, Revenues & Volume, By Application, 2021 - 2031 |
12.5 Middle East Pharmacogenomics Technology Market, Revenues & Volume, By Testing Method, 2021 - 2031 |
12.6 Middle East Pharmacogenomics Technology Market, Revenues & Volume, By End User, 2021 - 2031 |
12.7 Middle East Pharmacogenomics Technology Market, Revenues & Volume, By Market Driver, 2021 - 2031 |
13 Global Pharmacogenomics Technology Market Key Performance Indicators |
14 Global Pharmacogenomics Technology Market - Export/Import By Countries Assessment |
15 Global Pharmacogenomics Technology Market - Opportunity Assessment |
15.1 Global Pharmacogenomics Technology Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Pharmacogenomics Technology Market Opportunity Assessment, By Technology Type, 2021 & 2031F |
15.3 Global Pharmacogenomics Technology Market Opportunity Assessment, By Application, 2021 & 2031F |
15.4 Global Pharmacogenomics Technology Market Opportunity Assessment, By Testing Method, 2021 & 2031F |
15.5 Global Pharmacogenomics Technology Market Opportunity Assessment, By End User, 2021 & 2031F |
15.6 Global Pharmacogenomics Technology Market Opportunity Assessment, By Market Driver, 2021 & 2031F |
16 Global Pharmacogenomics Technology Market - Competitive Landscape |
16.1 Global Pharmacogenomics Technology Market Revenue Share, By Companies, 2024 |
16.2 Global Pharmacogenomics Technology Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |